SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-10.97%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$405M
AUM Growth
+$405M
(-25%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-14.49%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
122
New
18
Increased
18
Reduced
51
Closed
9
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$4.36M |
| 2 |
Nova
NVMI
|
$4.16M |
| 3 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$3.91M |
| 4 |
Sarepta Therapeutics
SRPT
|
$3.77M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$3.47M |
Top Sells
| 1 |
BridgeBio Pharma
BBIO
|
$18.6M |
| 2 |
Microsoft
MSFT
|
$6.66M |
| 3 |
Meta Platforms (Facebook)
META
|
$6.36M |
| 4 |
Check Point Software Technologies
CHKP
|
$6.22M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$5.29M |
Sector Composition
| 1 | Healthcare | 78.9% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 2.19% |
| 4 | Communication Services | 2.14% |
| 5 | Utilities | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SolarEdge
SEDG
$1.97B
| $5M | 1.15% |
309,216
-65,784
| -18% | -$1.06M |
|
27
89bio
ETNB
$1.37B
| $4.5M | 1.04% |
618,343
+61,811
| +11% | +$449K |
|
28
Merus
MRUS
$5.04B
| $4.48M | 1.03% |
106,532
-24,000
| -18% | -$1.01M |
|
29
Immatics
IMTX
$662M
| $4.15M | 0.96% |
921,111
| – | – |
|
30
Apellis Pharmaceuticals
APLS
$3.51B
| $3.97M | 0.91% |
181,346
-24,905
| -12% | -$545K |
|
|
MAZE
31
Maze Therapeutics, Inc. Common Stock
MAZE
$666M
| $3.91M | 0.9% |
+355,554
| New | +$3.91M |
|
32
Travere Therapeutics
TVTX
$1.75B
| $3.58M | 0.83% |
200,000
-20,700
| -9% | -$371K |
|
33
Savara
SVRA
$591M
| $3.56M | 0.82% |
1,284,151
+72,618
| +6% | +$201K |
|
34
Arrowhead Research
ARWR
$3.84B
| $3.54M | 0.81% |
277,550
+80,000
| +40% | +$1.02M |
|
35
Dyne Therapeutics
DYN
$1.92B
| $3.44M | 0.79% |
329,262
+93,000
| +39% | +$973K |
|
36
Annexon
ANNX
$225M
| $3.41M | 0.78% |
1,764,387
+521,348
| +42% | +$1.01M |
|
37
Janux Therapeutics
JANX
$1.38B
| $3.4M | 0.78% |
125,840
+57,507
| +84% | +$1.55M |
|
|
CYBN
38
Cybin
CYBN
$142M
| $3.34M | 0.77% |
527,222
-10,889
| -2% | -$69K |
|
39
Immunovant
IMVT
$2.91B
| $3.33M | 0.77% |
+194,638
| New | +$3.33M |
|
40
NVIDIA
NVDA
$4.15T
| $3.21M | 0.74% |
+29,605
| New | +$3.21M |
|
41
Rezolute
RZLT
$630M
| $3.14M | 0.72% |
1,081,447
-84,448
| -7% | -$245K |
|
42
Avidity Biosciences
RNA
$6.12B
| $3.13M | 0.72% |
+106,000
| New | +$3.13M |
|
43
Amgen
AMGN
$153B
| $3.12M | 0.72% |
+10,000
| New | +$3.12M |
|
44
Biogen
BIIB
$20.8B
| $3.11M | 0.72% |
22,738
| – | – |
|
|
ACOG
45
Alpha Cognition Inc. Common Stock
ACOG
$132M
| $3.02M | 0.7% |
596,992
-23,008
| -4% | -$116K |
|
|
VIGL
46
DELISTED
Vigil Neuroscience
VIGL
| $2.86M | 0.66% |
1,604,429
+102,000
| +7% | +$182K |
|
47
Intellia Therapeutics
NTLA
$1.26B
| $2.71M | 0.62% |
381,080
-85,000
| -18% | -$604K |
|
48
Day One Biopharmaceuticals
DAWN
$766M
| $2.66M | 0.61% |
334,987
| – | – |
|
49
Applied Materials
AMAT
$124B
| $2.61M | 0.6% |
+18,000
| New | +$2.61M |
|
50
Scholar Rock
SRRK
$3.3B
| $2.51M | 0.58% |
78,193
-12,000
| -13% | -$386K |
|